The venture aims to advance MeiraGTx’s Parkinson’s gene therapy through Phase III trials with up to $430m in funding from ...

The EC has approved Otsuka Pharmaceutical and Lundbeck’s atypical oral antipsychotic, Rxulti (brexpiprazole), for treating ...

Insilico Medicine has completed a Series E round, raising $110m to progress the development of its pipeline of drugs and AI ...

Halo Pharmaceutical is a privately owned full service FDA, BLA and DEA (Schedule II-V) compliant CDMO, headquartered in ...

The two companies are merging after previously filing for bankruptcy due to opioid-related litigation and financial losses.

A day after announcing a business split-off to focus on weight loss and diabetes implants, Vivani Medical has implanted the ...

Emergent has entered a strategic financial investment agreement with Swiss Rockets to support the latter’s biotech portfolio.

Vivace Therapeutics has closed $35m in a Series D financing round to support the clinical development of its cancer drug ...

NICE estimates that 1,000 women could benefit from Ryeqo, which can be taken once-daily up until the menopause.

Telix states its automated and high-throughput generator can produce sufficient lead-212 elution for up to 60 clinical doses, ...

Atsena Therapeutics has received fast track designation from the FDA for ATSN-201, aimed at treating X-linked retinoschisis ...

The two companies will work together on Zealand’s amylin analogue petrelintide as a monotherapy and in combination therapies.